Literature DB >> 7544460

Mutational analysis of the reverse transcriptase and ribonuclease H domains of the human foamy virus.

D Kögel1, M Aboud, R M Flügel.   

Abstract

Human foamy or spuma virus (HFV) codes for a distinct set of pol gen products. To determine the minimal requirements for the HFV enzymatic activities, defined residues of the reverse transcriptase (RT) and ribo-nuclease H (RNase H) domain of the HFV pol gene were mutated by site-specific PCR mutagenesis. The mutant gene products were bacterially expressed, purified by Ni2+ chelate affinity chromatography and characterised by Western blotting. The enzymatic activities of the individual recombinant HFV pol mutant proteins were characterised by the situ RT, RNase H and RNase H assays. Two substitution mutants reached RT activity levels higher than that of the intact recombinant HFV RT-RH-His. When the catalytically essential D508 was substituted by A508, 5% of RNase H activity was retained while DNA polymerase activity increased 2-fold. A deletion of 11 amino acid residues in the hinge region completely abolished DNA polymerase while RNase H activity decreased 2-fold. A deletion mutant in the C-terminal RH domain showed no RNase H but retained RNase H activity indicating that the activities are genetically separable. The combined data reveal that the HFV DNA polymerase and RNase H activities are interdependent.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544460      PMCID: PMC307083          DOI: 10.1093/nar/23.14.2621

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  24 in total

1.  Characterization of the double stranded RNA dependent RNase activity associated with recombinant reverse transcriptases.

Authors:  H Ben-Artzi; E Zeelon; S F Le-Grice; M Gorecki; A Panet
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

Review 2.  Replication and regulation of primate foamy viruses.

Authors:  A Mergia; P A Luciw
Journal:  Virology       Date:  1991-10       Impact factor: 3.616

3.  Use of T7 RNA polymerase to direct expression of cloned genes.

Authors:  F W Studier; A H Rosenberg; J J Dunn; J W Dubendorff
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

4.  Association of viral reverse transcriptase with an enzyme degrading the RNA moiety of RNA-DNA hybrids.

Authors:  K Mölling; D P Bolognesi; H Bauer; W Büsen; H W Plassmann; P Hausen
Journal:  Nat New Biol       Date:  1971-12-22

5.  Intrinsic properties of reverse transcriptase in reverse transcription. Associated RNase H is essentially regarded as an endonuclease.

Authors:  F Oyama; R Kikuchi; R J Crouch; T Uchida
Journal:  J Biol Chem       Date:  1989-11-05       Impact factor: 5.157

6.  Polymerization and RNase H activities of the reverse transcriptases from avian myeloblastosis, human immunodeficiency, and Moloney murine leukemia viruses are functionally uncoupled.

Authors:  J J DeStefano; R G Buiser; L M Mallaber; T W Myers; R A Bambara; P J Fay
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

7.  Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel 1 gene.

Authors:  M Löchelt; H Zentgraf; R M Flügel
Journal:  Virology       Date:  1991-09       Impact factor: 3.616

8.  Mutational analysis of the fingers domain of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  P L Boyer; A L Ferris; S H Hughes
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

9.  HIV-1 RT-associated ribonuclease H displays both endonuclease and 3'----5' exonuclease activity.

Authors:  O Schatz; J Mous; S F Le Grice
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

10.  Identification and characterization of HIV-specific RNase H by monoclonal antibody.

Authors:  J Hansen; T Schulze; W Mellert; K Moelling
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

View more
  8 in total

1.  Human foamy virus reverse transcription that occurs late in the viral replication cycle.

Authors:  A Moebes; J Enssle; P D Bieniasz; M Heinkelein; D Lindemann; M Bock; M O McClure; A Rethwilm
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 2.  Analysis of the phylogenetic placement of different spumaretroviral genes reveals complex pattern of foamy virus evolution.

Authors:  H W Dias; M Aboud; R M Flügel
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

3.  Expression and maturation of human foamy virus Gag precursor polypeptides.

Authors:  M L Giron; S Colas; J Wybier; F Rozain; R Emanoil-Ravier
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

4.  Proteolytic activity, the carboxy terminus of Gag, and the primer binding site are not required for Pol incorporation into foamy virus particles.

Authors:  D N Baldwin; M L Linial
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

5.  Biophysical and enzymatic properties of the simian and prototype foamy virus reverse transcriptases.

Authors:  Maximilian J Hartl; Florian Mayr; Axel Rethwilm; Birgitta M Wöhrl
Journal:  Retrovirology       Date:  2010-01-29       Impact factor: 4.602

6.  The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein.

Authors:  M Löchelt; R M Flügel
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

7.  AZT-resistant foamy virus.

Authors:  Benedikt Kretzschmar; Ali Nowrouzi; Maximilian J Hartl; Kathleen Gärtner; Tatiana Wiktorowicz; Ottmar Herchenröder; Sylvia Kanzler; Wolfram Rudolph; Ayalew Mergia; Birgitta Wöhrl; Axel Rethwilm
Journal:  Virology       Date:  2007-09-27       Impact factor: 3.616

8.  The simian foamy virus type 1 transcriptional transactivator (Tas) binds and activates an enhancer element in the gag gene.

Authors:  M Campbell; C Eng; P A Luciw
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.